Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-05-14 | Laurie Smaldone Alsup, New Jersey, United States (Independent Director) Dr. Laurie Smaldone Alsup, 66, has served as a director of the Company since June 2015. ... Board/Committee Membership Attendance Name of Issuer Period of Service Board 5/5 100% Current Boards Theravance Biopharma, Inc. 2018 - present Audit and Risk Management Committee 4/4 100% Arvinas, Inc. 2019 - present Overall attendance 9/9 100% Other Boards in Past 5 Years Kalobios Pharmaceuticals, Inc. 2013 - 2015 Board Interlock None Skills and Qualifications Executive Leadership Regulatory Affairs Risk Management Securities Held Total Common Total value of Common Common Shares (#) DSUs (#) Shares/DSUs (#) Shares/DSUs As of the Record Date - 120,935 120,935 $515,183 Annual Meeting Voting Results Year Votes For % of Votes For Votes Withheld % of Votes Withheld 2019 279,689,940 99.45% 1,553,521 0.55% 13 |
| 2021-05-10 | Dr. Laurie Smaldone Alsup, 67, has served as a director of the Company since June 2015. ... Audit and Risk Management Committee member. ... Director Compensation Table shows total fees earned $202,338. |
| 2022-05-10 | Dr. Laurie Smaldone Alsup, 68, has served as a director of the Company since June 2015. ... Director Compensation Table ... Laurie Smaldone Alsup $215,517 |
| 2023-05-16 | Dr. Laurie Smaldone Alsup, 69, has served as a director of the Company since June 2015. Dr. Smaldone Alsup’s total fees earned in Fiscal 2023 were $205,558. |
Data sourced from SEC filings. Last updated: 2026-03-14